These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32416311)

  • 1. Periprocedural Outcomes in Patients on Chronic Anticoagulation Undergoing Fistulograms.
    Paredes LG; Arinze NV; Farber A; Garofalo D; Cheng TW; Levin SR; Vilvendhan R; Siracuse JJ
    Ann Vasc Surg; 2021 Jan; 70():123-130. PubMed ID: 32416311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success of endovenous saphenous and perforator ablation in patients with symptomatic venous insufficiency receiving long-term warfarin therapy.
    Gabriel V; Jimenez JC; Alktaifi A; Lawrence PF; O'Connell J; Derubertis BG; Rigberg DA; Gelabert HA
    Ann Vasc Surg; 2012 Jul; 26(5):607-11. PubMed ID: 22516240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of systemic anticoagulation in patients undergoing angioaccess surgery.
    D'Ayala M; Smith RM; Martone C; Briggs W; Deitch JS; Wise L
    Ann Vasc Surg; 2008 Jan; 22(1):11-5. PubMed ID: 18055171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.
    Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R
    Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.
    LeSar CJ; Merrick HW; Smith MR
    J Am Coll Surg; 1999 Jul; 189(1):73-9; discussion 79-81. PubMed ID: 10401743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peri-operative Anticoagulation Strategies, Bleeding and Thrombotic Complications in Pediatric Patients Undergoing Intervention for Congenital Portosystemic Shunts.
    Haimed A; Brandt KA; Badawy S; Lemoine CP; Bhat R; Superina R
    J Pediatr Surg; 2024 Oct; 59(10):161609. PubMed ID: 39098434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation.
    Tapanainen JM; Braunschweig F; Schwieler J; Insulander P; Bastani H; Drca N; Kennebäck G; Sadigh B; Jensen-Urstad M
    Scand Cardiovasc J; 2013 Apr; 47(2):109-13. PubMed ID: 23098247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural bridging anticoagulation: current perspectives.
    Palaniswamy C; Selvaraj DR
    Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
    Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalent outcomes with standard and heparin-bonded expanded polytetrafluoroethylene grafts used as conduits for hemodialysis access.
    Davies MG; Anaya-Ayala JE; El-Sayed HF
    J Vasc Surg; 2016 Sep; 64(3):715-8. PubMed ID: 27183857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
    Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
    J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
    Weeda ER; Kohn CG; Peacock WF; Fermann GJ; Crivera C; Schein JR; Coleman CI
    Pharmacotherapy; 2016 Oct; 36(10):1109-1115. PubMed ID: 27548074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.
    Lahtela H; Rubboli A; Schlitt A; Karjalainen PP; Niemelä M; Vikman S; Puurunen M; Weber M; Valencia J; Biancari F; Lip GY; Airaksinen KE;
    Circ J; 2012; 76(6):1363-8. PubMed ID: 22447005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency and laser vein ablation for patients receiving warfarin anticoagulation is safe, effective, and durable.
    Westin GG; Cayne NS; Lee V; Ekstroem J; Yau PO; Sadek M; Rockman CB; Kabnick LS; Berland TL; Maldonado TS; Jacobowitz GR
    J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):610-616. PubMed ID: 31987758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment.
    Hakalahti A; Uusimaa P; Ylitalo K; Raatikainen MJ
    Europace; 2011 May; 13(5):640-5. PubMed ID: 21398311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
    Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
    Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis.
    O'shea SI; Lawson JH; Reddan D; Murphy M; Ortel TL
    J Vasc Surg; 2003 Sep; 38(3):541-8. PubMed ID: 12947274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.